HOME
ABOUT
FACULTY
AGENDA
VENUE
REGISTRATION
SPONSORS
HCC NEWS & LIBRARY
CONTACT
More
ARTICLES:
FDA grants accelerated approval to pembrolizumab for hepatocellular carcinoma
Genentech’s Tecentriq in Combination With Avastin Increased Overall Survival and Progression-Free Survival in People With Unresectable Hepatocellular Carcinoma
Bristol-Myers Squibb Announces Results from CheckMate -459 Study Evaluating Opdivo (nivolumab) as a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma